JP2006521550A - 化合物を分析するための方法及びシステム - Google Patents
化合物を分析するための方法及びシステム Download PDFInfo
- Publication number
- JP2006521550A JP2006521550A JP2006505994A JP2006505994A JP2006521550A JP 2006521550 A JP2006521550 A JP 2006521550A JP 2006505994 A JP2006505994 A JP 2006505994A JP 2006505994 A JP2006505994 A JP 2006505994A JP 2006521550 A JP2006521550 A JP 2006521550A
- Authority
- JP
- Japan
- Prior art keywords
- features
- compound
- array
- compounds
- data
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 77
- 238000000034 method Methods 0.000 title claims abstract description 25
- 238000004458 analytical method Methods 0.000 claims abstract description 29
- 230000004044 response Effects 0.000 claims abstract description 22
- 238000001514 detection method Methods 0.000 claims abstract description 8
- 239000013598 vector Substances 0.000 claims description 27
- 230000008859 change Effects 0.000 claims description 15
- 238000003860 storage Methods 0.000 claims description 12
- 239000000758 substrate Substances 0.000 claims description 8
- 238000007621 cluster analysis Methods 0.000 claims description 2
- 238000004590 computer program Methods 0.000 claims 2
- 238000003491 array Methods 0.000 claims 1
- 230000000717 retained effect Effects 0.000 claims 1
- 238000012545 processing Methods 0.000 abstract description 13
- 239000003814 drug Substances 0.000 abstract description 10
- 230000001413 cellular effect Effects 0.000 abstract description 9
- 230000007613 environmental effect Effects 0.000 abstract description 6
- 239000002537 cosmetic Substances 0.000 abstract description 3
- 238000012360 testing method Methods 0.000 description 48
- 210000004027 cell Anatomy 0.000 description 36
- 230000000694 effects Effects 0.000 description 22
- 239000006185 dispersion Substances 0.000 description 18
- 238000005259 measurement Methods 0.000 description 14
- 229940079593 drug Drugs 0.000 description 8
- 231100000614 poison Toxicity 0.000 description 8
- 238000011084 recovery Methods 0.000 description 8
- 241000894007 species Species 0.000 description 8
- 238000004422 calculation algorithm Methods 0.000 description 7
- 230000010412 perfusion Effects 0.000 description 7
- 239000002574 poison Substances 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 210000004413 cardiac myocyte Anatomy 0.000 description 6
- VZFRNCSOCOPNDB-AJKFJWDBSA-N domoic acid Chemical compound OC(=O)[C@@H](C)\C=C\C=C(/C)[C@H]1CN[C@H](C(O)=O)[C@H]1CC(O)=O VZFRNCSOCOPNDB-AJKFJWDBSA-N 0.000 description 6
- VZFRNCSOCOPNDB-UHFFFAOYSA-N domoic acid Natural products OC(=O)C(C)C=CC=C(C)C1CNC(C(O)=O)C1CC(O)=O VZFRNCSOCOPNDB-UHFFFAOYSA-N 0.000 description 6
- VZFRNCSOCOPNDB-OXYNIABMSA-N isodomoic acid D Natural products CC(C=C/C=C(/C)C1CNC(C1CC(=O)O)C(=O)O)C(=O)O VZFRNCSOCOPNDB-OXYNIABMSA-N 0.000 description 6
- 238000005070 sampling Methods 0.000 description 6
- 238000012935 Averaging Methods 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 230000003595 spectral effect Effects 0.000 description 5
- 239000003053 toxin Substances 0.000 description 5
- 231100000765 toxin Toxicity 0.000 description 5
- 108700012359 toxins Proteins 0.000 description 5
- 230000036982 action potential Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 235000015170 shellfish Nutrition 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000002123 temporal effect Effects 0.000 description 4
- 238000013459 approach Methods 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- 229930182816 L-glutamine Natural products 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 102000004338 Transferrin Human genes 0.000 description 2
- 108090000901 Transferrin Proteins 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 230000003542 behavioural effect Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000003915 cell function Effects 0.000 description 2
- 230000001054 cortical effect Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000005003 heart tissue Anatomy 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 229940082569 selenite Drugs 0.000 description 2
- MCAHWIHFGHIESP-UHFFFAOYSA-L selenite(2-) Chemical compound [O-][Se]([O-])=O MCAHWIHFGHIESP-UHFFFAOYSA-L 0.000 description 2
- 239000000238 shellfish toxin Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000012581 transferrin Substances 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000237509 Patinopecten sp. Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 1
- 238000013528 artificial neural network Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000003855 balanced salt solution Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000008238 biochemical pathway Effects 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000036755 cellular response Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 210000003618 cortical neuron Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000013481 data capture Methods 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 231100000317 environmental toxin Toxicity 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000002064 heart cell Anatomy 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000028161 membrane depolarization Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000001769 paralizing effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000002572 performance enhancing substance Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 238000004886 process control Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000010223 real-time analysis Methods 0.000 description 1
- 238000009781 safety test method Methods 0.000 description 1
- 229960002052 salbutamol Drugs 0.000 description 1
- 235000020637 scallop Nutrition 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000011524 similarity measure Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/70—Machine learning, data mining or chemometrics
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/50—Molecular design, e.g. of drugs
Landscapes
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Evolutionary Computation (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Software Systems (AREA)
- Health & Medical Sciences (AREA)
- Artificial Intelligence (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- Computing Systems (AREA)
- Theoretical Computer Science (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0307352.5A GB0307352D0 (en) | 2003-03-29 | 2003-03-29 | Improvements in and relating to the analysis of compounds |
| PCT/GB2004/001228 WO2004088536A2 (en) | 2003-03-29 | 2004-03-23 | Method and system for analysis of compounds |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011235495A Division JP5542285B2 (ja) | 2003-03-29 | 2011-10-26 | 化合物を分析するための方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2006521550A true JP2006521550A (ja) | 2006-09-21 |
Family
ID=9955846
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006505994A Withdrawn JP2006521550A (ja) | 2003-03-29 | 2004-03-23 | 化合物を分析するための方法及びシステム |
| JP2011235495A Expired - Fee Related JP5542285B2 (ja) | 2003-03-29 | 2011-10-26 | 化合物を分析するための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011235495A Expired - Fee Related JP5542285B2 (ja) | 2003-03-29 | 2011-10-26 | 化合物を分析するための方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US10140427B2 (enExample) |
| EP (1) | EP1609091B1 (enExample) |
| JP (2) | JP2006521550A (enExample) |
| GB (1) | GB0307352D0 (enExample) |
| WO (1) | WO2004088536A2 (enExample) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009538433A (ja) * | 2006-05-26 | 2009-11-05 | ジーイー・ヘルスケア・バイオサイエンス・コーポレイション | 容器中のパラメータを監視するシステム及び方法 |
| JP2016529889A (ja) * | 2013-07-26 | 2016-09-29 | アクシオン バイオシステムズ， インコーポレイテッド | ハイスループット電気生理機能のためのデバイス、システム、及び方法 |
| US10067117B2 (en) | 2014-08-12 | 2018-09-04 | Axion Biosystems, Inc. | Cell-based biosensor array and associated methods for manufacturing the same |
| WO2021230138A1 (ja) * | 2020-05-11 | 2021-11-18 | アルファメッドサイエンティフィック株式会社 | 解析方法および解析装置 |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0307352D0 (en) | 2003-03-29 | 2003-05-07 | Qinetiq Ltd | Improvements in and relating to the analysis of compounds |
| CN103141067B (zh) * | 2010-08-30 | 2016-11-09 | 新加坡科技研究局 | 频带识别方法、装置 |
| US9094493B2 (en) | 2012-04-25 | 2015-07-28 | Compliance Software, Inc. | Capturing and processing instant drug test results using a mobile device |
| MX362826B (es) | 2012-04-25 | 2019-02-18 | Compliance Software Inc | Captura y procesamiento de resultados instantaneos de prueba de deteccion de drogas utilizando un dispositivo movil. |
| USD701320S1 (en) | 2012-04-25 | 2014-03-18 | Compliance Software, Inc. | Adaptable housing for mobile device based drug testing |
| TWI619809B (zh) * | 2012-08-24 | 2018-04-01 | 佐竹股份有限公司 | 微生物之檢查方法及其裝置 |
| JP6221210B2 (ja) * | 2012-09-11 | 2017-11-01 | 株式会社サタケ | 微生物の検査方法及びその装置 |
| US10430395B2 (en) * | 2017-03-01 | 2019-10-01 | International Business Machines Corporation | Iterative widening search for designing chemical compounds |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10170422A (ja) * | 1996-12-12 | 1998-06-26 | Sanyo Electric Co Ltd | 複合型匂いセンサ |
| WO2002004943A2 (en) * | 2000-07-07 | 2002-01-17 | Bristol-Myers Squibb Company | Electrophysiology configuration suitable for high throughput screening of compounds for drug discovery |
| US6377057B1 (en) * | 1999-02-18 | 2002-04-23 | The Board Of Trustees Of The Leland Stanford Junior University | Classification of biological agents according to the spectral density signature of evoked changes in cellular electric potential |
| JP2002533700A (ja) * | 1998-12-23 | 2002-10-08 | ロゼッタ・インファーマティクス・インコーポレーテッド | 生物学的応答信号データを解析するための方法およびシステム |
| WO2002099408A1 (fr) * | 2001-06-05 | 2002-12-12 | Matsushita Electric Industrial Co., Ltd. | Capteur de detection de signaux pourvu de multiples electrodes |
| WO2003017177A2 (en) * | 2001-08-13 | 2003-02-27 | Beyong Genomics, Inc. | Method and system for profiling biological systems |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6075879A (en) | 1993-09-29 | 2000-06-13 | R2 Technology, Inc. | Method and system for computer-aided lesion detection using information from multiple images |
| US5772983A (en) * | 1995-10-16 | 1998-06-30 | Worcester Foundation For Biomedical Research | Methods of screening for compounds which modulate insect behavior |
| US5981268A (en) * | 1997-05-30 | 1999-11-09 | Board Of Trustees, Leland Stanford, Jr. University | Hybrid biosensors |
| US6721754B1 (en) | 1999-04-28 | 2004-04-13 | Arena Pharmaceuticals, Inc. | System and method for database similarity join |
| AU780409B2 (en) * | 1999-05-21 | 2005-03-17 | James J. Hickman | High throughput functional genomics |
| HK1047027B (en) | 1999-12-28 | 2009-05-08 | RF Science & Technology, Inc. | Method and apparatus for non-invasive analysis of blood glucose |
| US7058658B2 (en) * | 2000-03-28 | 2006-06-06 | Dana-Farber Cancer Institute, Inc. | Molecular database for antibody characterization |
| GB0117715D0 (en) | 2001-07-19 | 2001-09-12 | Mrbp Res Ltd | Microwave biochemical analysis |
| CA2457391A1 (en) * | 2001-08-06 | 2003-02-20 | Vanderbilt University | Device and methods for detecting the response of a plurality of cells to at least one analyte of interest |
| EP1442141A4 (en) * | 2001-10-17 | 2005-05-18 | Univ Utah Res Found | METHOD FOR IDENTIFYING DIFFERENTIALLY EXPRESSED GENES THROUGH MULTIVARIATE ANALYSIS OF MICROARRAY DATA |
| US6993440B2 (en) | 2002-04-22 | 2006-01-31 | Harris Corporation | System and method for waveform classification and characterization using multidimensional higher-order statistics |
| GB0307352D0 (en) | 2003-03-29 | 2003-05-07 | Qinetiq Ltd | Improvements in and relating to the analysis of compounds |
| JP5332647B2 (ja) | 2009-01-23 | 2013-11-06 | 日本電気株式会社 | モデル選択装置、モデル選択装置の選択方法及びプログラム |
-
2003
- 2003-03-29 GB GBGB0307352.5A patent/GB0307352D0/en not_active Ceased
-
2004
- 2004-03-23 JP JP2006505994A patent/JP2006521550A/ja not_active Withdrawn
- 2004-03-23 EP EP04722582.6A patent/EP1609091B1/en not_active Expired - Lifetime
- 2004-03-23 US US10/551,070 patent/US10140427B2/en not_active Expired - Fee Related
- 2004-03-23 WO PCT/GB2004/001228 patent/WO2004088536A2/en not_active Ceased
-
2011
- 2011-10-26 JP JP2011235495A patent/JP5542285B2/ja not_active Expired - Fee Related
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10170422A (ja) * | 1996-12-12 | 1998-06-26 | Sanyo Electric Co Ltd | 複合型匂いセンサ |
| JP2002533700A (ja) * | 1998-12-23 | 2002-10-08 | ロゼッタ・インファーマティクス・インコーポレーテッド | 生物学的応答信号データを解析するための方法およびシステム |
| US6377057B1 (en) * | 1999-02-18 | 2002-04-23 | The Board Of Trustees Of The Leland Stanford Junior University | Classification of biological agents according to the spectral density signature of evoked changes in cellular electric potential |
| WO2002004943A2 (en) * | 2000-07-07 | 2002-01-17 | Bristol-Myers Squibb Company | Electrophysiology configuration suitable for high throughput screening of compounds for drug discovery |
| WO2002099408A1 (fr) * | 2001-06-05 | 2002-12-12 | Matsushita Electric Industrial Co., Ltd. | Capteur de detection de signaux pourvu de multiples electrodes |
| WO2003017177A2 (en) * | 2001-08-13 | 2003-02-27 | Beyong Genomics, Inc. | Method and system for profiling biological systems |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009538433A (ja) * | 2006-05-26 | 2009-11-05 | ジーイー・ヘルスケア・バイオサイエンス・コーポレイション | 容器中のパラメータを監視するシステム及び方法 |
| JP2016529889A (ja) * | 2013-07-26 | 2016-09-29 | アクシオン バイオシステムズ， インコーポレイテッド | ハイスループット電気生理機能のためのデバイス、システム、及び方法 |
| US10067117B2 (en) | 2014-08-12 | 2018-09-04 | Axion Biosystems, Inc. | Cell-based biosensor array and associated methods for manufacturing the same |
| WO2021230138A1 (ja) * | 2020-05-11 | 2021-11-18 | アルファメッドサイエンティフィック株式会社 | 解析方法および解析装置 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1609091B1 (en) | 2019-01-09 |
| EP1609091A2 (en) | 2005-12-28 |
| GB0307352D0 (en) | 2003-05-07 |
| US10140427B2 (en) | 2018-11-27 |
| JP5542285B2 (ja) | 2014-07-09 |
| JP2012053056A (ja) | 2012-03-15 |
| US20060177869A1 (en) | 2006-08-10 |
| WO2004088536A3 (en) | 2005-03-24 |
| WO2004088536A2 (en) | 2004-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5542285B2 (ja) | 化合物を分析するための方法 | |
| Bologna et al. | Investigating neuronal activity by SPYCODE multi-channel data analyzer | |
| Matteucci et al. | Nonlinear processing of shape information in rat lateral extrastriate cortex | |
| Gerrard et al. | Sequence reactivation in the hippocampus is impaired in aged rats | |
| McMahon et al. | One month in the life of a neuron: longitudinal single-unit electrophysiology in the monkey visual system | |
| Nádasdy et al. | Extracellular recording and analysis of neuronal activity: from single cells to ensembles | |
| US20040106101A1 (en) | System and method for quality control of a shipped neural cell culture on a microelectrode array | |
| KR100542422B1 (ko) | 유의 신호의 추출 방법, 기록 매체 및 프로그램 | |
| EP1921989A2 (en) | Neuronal avalanche assay | |
| Yang et al. | A biosensing system employing nonlinear dynamic analysis-assisted neural network for drug-induced cardiotoxicity assessment | |
| Ouyang et al. | Multi-labeled neural network model for automatically processing cardiomyocyte mechanical beating signals in drug assessment | |
| US20120221256A1 (en) | Functional characterization of biological samples | |
| EP1444506A2 (en) | Detection and characterization of pyschoactives using parallel multi-site assays in neuronal tissue | |
| Merre et al. | A Prefrontal Cortex Map based on Single Neuron Activity | |
| WO2021230138A1 (ja) | 解析方法および解析装置 | |
| Lee et al. | CardioMEA: comprehensive data analysis platform for studying cardiac diseases and drug responses | |
| EP4560314A1 (en) | Method and device for high-resolution spatial and temporal mapping of large-scale electrophysiological dynamics and transcriptional profiles within intact brain tissues | |
| JPH0314127B2 (enExample) | ||
| Mendis et al. | Use of local field potentials of dissociated cultures grown on multi-electrode arrays for pharmacological assays | |
| US20250109371A1 (en) | Devices, systems, and methods for organoid analysis | |
| Hu et al. | Maagdenberg | |
| Altunkaya | Automating synaptic plasticity analysis: A deep learning approach to segmenting hippocampal field potential signal | |
| WO2025204132A1 (ja) | 情報処理装置、情報処理装置の作動方法、および情報処理装置の作動プログラム | |
| CN120508823A (zh) | 一种基于人工神经网络的胞内电信号无创重构方法及系统 | |
| CN119082026A (zh) | 一种脐带血干细胞的活性检测方法及系统 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070322 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100301 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100527 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100603 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100901 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20101004 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20101220 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20101228 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110401 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110427 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110721 |
|
| RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20110721 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20110721 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110826 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110926 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111026 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20111026 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20111012 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20111026 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20111125 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20111213 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120411 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20120418 |
|
| A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20120525 |
|
| A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20140212 |